Skip to main content

Vance Garrison Fowler Jr.

Florence McAlister Distinguished Professor of Medicine
Medicine, Infectious Diseases
Duke Box 102359, Hanes House, Trent Drive, Durham, NC 27710
Room 183, Hanes House, 315 Trent Drive, Durham, NC 27710

Selected Grants


Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2022 - 2027

Staphylococcus aureus Cardiac Device Infections - From the Vascular Viewpoint (K23)

ResearchMentor · Awarded by National Institutes of Health · 2022 - 2027

Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality

ResearchMentor · Awarded by National Institutes of Health · 2022 - 2027

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2022 - 2027

Staphylococcus aureus Cardiac Device Infections - From the Vascular Viewpoint (K23)

ResearchMentor · Awarded by National Institutes of Health · 2022 - 2027

Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality

ResearchMentor · Awarded by National Institutes of Health · 2022 - 2027

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Antibacterial Resistance Leadership Group (ARLG)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2026

HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01 RPPR

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026

Innate immune induction of antibiotic tolerance and resistance in Staphylococcus aureus - R56 Bridge Funding (for R01 submission)

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2022 - 2024

Molecular Mycology and Pathogenesis Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2024

Parsons UNC Interinstitutional Agreement

FellowshipPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2024

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

Characterizing the quality of life impact of complicated urinary tract infections caused by gram-negative bacteria

ResearchCo-Principal Investigator · Awarded by Merck Sharp & Dohme · 2021 - 2024

Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2023

Postdoctoral Training in Genomic Medicine Research

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023

A Photochemically 3D Printed High-Resolution Biodegradable Suture Retention Clip

ResearchPrincipal Investigator · Awarded by Deep Blue Medical Advances Inc · 2022 - 2023

CEC Activities for BPR-CS-009 Ceftobiprole medocaril - WO2

Clinical TrialPrincipal Investigator · Awarded by Basilea Pharmaceutica · 2018 - 2022

CEC Activities for BPR-CS-009 Ceftobiprole medocaril

Clinical TrialPrincipal Investigator · Awarded by Basilea Pharmaceutica · 2017 - 2022

Computational Structure-Based Protein Design Non-competing Renewal (Yr. 12)

ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2008 - 2022

Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2022

Vaccine Trial_LOI

ResearchPrincipal Investigator · Awarded by Universitair Medisch Centrum Utrecht · 2019 - 2021

Systems Immunobiology of Antibiotic-Persistent MRSA Infections

ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2016 - 2021

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021

Diagnosis of Bacteremia/Septicemia by the Karius sequencing-based Infectious disease diagnostic assay

Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2016 - 2021

Study of Prognostic Biomarkers of Severe Systemic Bacterial Infection

ResearchPrincipal Investigator · Awarded by Genetech · 2016 - 2020

Study Network of Acinetobacter as a XDR pathogen (SNAP)

Clinical TrialPrincipal Investigator · Awarded by University of Pittsburgh · 2018 - 2020

CF-301-102 Study

Clinical TrialPrincipal Investigator · Awarded by ContraFect Corporation · 2016 - 2020

Forces at the heart of Staphylococcus biofilms on cardiac implants

ResearchPrincipal Investigator · Awarded by Ohio State University · 2014 - 2020

Host Susceptibility to S. aureus

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2020

CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia-a Randomized Controlled Trial

ResearchPrincipal Investigator · Awarded by Menzies School of Health Research · 2015 - 2019

ARLG Administrative Supplement

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019

One Health Innovation Fellowships for Zoonotic Disease Research in Mongolia

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2013 - 2019

Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2019

Bacteremia Modification 14

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017

Mod 11 for Option 3 - Staphylococcal Bacteremia Study

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017

Modification No 13 Staphylococcal Bacteremia Study

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2017

Institutional Training Grant in Pediatric Infectious Disease

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2011 - 2016

Modification No. 8 - Staphylococcal Bacteremia Study

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2016

Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Community Hospital

ResearchCo-Mentor · Awarded by National Institutes of Health · 2011 - 2016

Modification No. 5 - Staphylococcal Bacteremia Study

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2015

Optimizing duration of antibiotics after valve surgery for infective endocarditis

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2012 - 2014

Immune System Biological Networks:Case Study Improved Data Integration & Analysis

ResearchCo Investigator · Awarded by National Institutes of Health · 2008 - 2010

Virulence determinants in S. aureus bacteremia

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2008

Towards an Understanding of the Pathophysiology and Clinical Outcomes of Patients w/Endocarditis

ResearchCollaborator · Awarded by National Institutes of Health · 2002 - 2006

Towards an Understanding of the Pathogenesis of Staphylococcus Aureus Bacteremia

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2005

External Relationships


  • ArcBio
  • Armata
  • Astra Zeneca
  • Basilea
  • Contrafect
  • ArcBio
  • Armata
  • Astra Zeneca
  • Basilea
  • Contrafect
  • DebioPharma
  • Destiny Pharma
  • GSK
  • INfectious Diseases Society of America
  • Integrated biotherapeutics
  • Pfizer Inc.
  • Valanbio Therapeutics
  • Wolters Kluwer Health (publishing)

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.